MedTrace Logo

Optimal Protein Supplementation for Critically Ill Patients

NCT01934595 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-06-07

No results posted yet for this study

Summary

It is well accepted that during critical illness there is an increase in protein breakdown and loss of lean body mass. Previous studies have shown that during critical illness muscle breakdown increases dramatically. The aim of our study is to test the hypothesis that critically ill patients have improved outcomes with higher protein supplementation.

Conditions

  • Critical Illness

Interventions

DIETARY_SUPPLEMENT

Beneprotein

The study will compare different protein supplementation amounts to determine if increased protein supplementation in critically ill patients improves outcomes.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Karen S Allen, MD · OUHSC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-07-31
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01934595 on ClinicalTrials.gov